A
Alberto Fernandez
Publications - 20
Citations - 687
Alberto Fernandez is an academic researcher. The author has contributed to research in topics: Inflammatory bowel disease & Population. The author has an hindex of 12, co-authored 18 publications receiving 535 citations.
Papers
More filters
Journal ArticleDOI
Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study.
Johan Burisch,Gediminas Kiudelis,Limas Kupčinskas,Hendrika Adriana Linda Kievit,Karina Winther Andersen,Vibeke Andersen,Riina Salupere,Natalia Pedersen,Jens Kjeldsen,Renata D'Incà,D. Valpiani,Doron Schwartz,Selwyn Odes,J. Olsen,K R Nielsen,Zsuzsanna Vegh,Peter L. Lakatos,Alina Toca,Svetlana Turcan,Konstantinos H. Katsanos,Dimitrios K. Christodoulou,Mathurin Fumery,Corinne Gower-Rousseau,Stefania Chetcuti Zammit,Pierre Ellul,Carl Eriksson,Jonas Halfvarson,Fernando Magro,Dana Duricova,Martin Bortlik,Alberto Fernandez,Vicent Hernandez,Sally Myers,Shaji Sebastian,Pia Oksanen,Pekka Collin,Adrian Goldis,Ravi Misra,Naila Arebi,I. Kaimakliotis,Inna Nikuina,Elena Belousova,Marko Brinar,Silvija Čuković-Čavka,Ebbe Langholz,Pia Munkholm +45 more
TL;DR: Despite patients being treated early and frequently with immunomodulators and biological therapy in Western Europe, 5-year outcomes including surgery and phenotype progression in this cohort were comparable across Western and Eastern Europe.
Journal ArticleDOI
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
Z. Vegh,Z. Vegh,Johan Burisch,Niels C Pedersen,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Søren Avnstrøm,K. Kofod Vinding,J. Olsen,K R Nielsen,K.H. Katsanos,E.V. Tsianos,Laszlo Lakatos,Doron Schwartz,Shmuel Odes,Guido Lupinacci,A. De Padova,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,O Tighineanu,I Mihu,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Alberto Fernandez,Vicent Hernandez,O Niewiadomski,Sally Bell,Ebbe Langholz,Pia Munkholm,Peter L. Lakatos,EpiCom-group +34 more
TL;DR: Incidence rates, disease phenotype and initial treatment characteristics in the 2011 ECCO-EpiCom cohort were not significantly different from that reported in the 2010 cohort.
Journal ArticleDOI
Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort
Johan Burisch,Natalia Pedersen,S. Cukovic-Cavka,Nikša Turk,I. Kaimakliotis,Dana Duricova,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Susanne Krabbe,Vibeke Andersen,Vibeke Andersen,Frederik Dahlerup Jens,Jens Kjeldsen,Riina Salupere,Jóngerd Olsen,K R Nielsen,Pia Manninen,Pekka Collin,Konstantinnos H. Katsanos,Epameinondas V. Tsianos,K. Ladefoged,Laszlo Lakatos,Y. Bailey,Colm O'Morain,Doron Schwartz,Selwyn Odes,Matteo Martinato,Silvia Lombardini,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Inna Nikulina,Elena Belousova,Alberto Fernandez,Vicent Hernandez,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Her Hsin Tsai,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +48 more
TL;DR: Surgery and hospitalization rates did not differ between patients from eastern and western Europe, although more western European patients received biological agents and were comparable to previous population-based inception cohorts.
Journal ArticleDOI
Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
Johan Burisch,Hillel Vardi,Doron Schwartz,Michael Friger,Gediminas Kiudelis,Juozas Kupcinskas,Mathurin Fumery,Corinne Gower-Rousseau,Laszlo Lakatos,Peter L. Lakatos,Peter L. Lakatos,Renata D'Incà,Alessandro Sartini,D. Valpiani,M. Giannotta,Naila Arebi,Dana Duricova,Martin Bortlik,Stefania Chetcuti Zammit,Pierre Ellul,Natalia Pedersen,Jens Kjeldsen,Jóngerð Maria Miné Midjord,K R Nielsen,Karina Winther Andersen,Vibeke Andersen,Konstantinos H. Katsanos,Dimitrios K. Christodoulou,V Domislović,Zeljko Krznaric,Zeljko Krznaric,Shaji Sebastian,Shaji Sebastian,Pia Oksanen,Pekka Collin,Luísa Barros,Fernando Magro,Riina Salupere,Hendrika Adriana Linda Kievit,Adrian Goldis,I. Kaimakliotis,Jens Frederik Dahlerup,Carl Eriksson,Jonas Halfvarson,Alberto Fernandez,Vicent Hernandez,Svetlana Turcan,Elena Belousova,Ebbe Langholz,Pia Munkholm,Selwyn Odes,Nikša Turk,Silvija Čuković-Čavka,Anastasia Nicolaou,Milan Lukas,Olga Shonová,Birgitte Blichfeldt,Dorte Marker,Katrine Carlsen,Petra Weimers,Clays Aalykke,Karen Kudsk,Ida Vind,Niels Thorsgaard,Alexandros Skamnelos,Dimitrios Politis,Zsuzsanna Vegh,Peterne Demenyi,Szabina Nemethne Kramli,Giualia Dal Piaz,A. Santini,G. Girardin,Limas Kupčinskas,Laimas Virginijus Jonaitis,Irena Valantiene,Romanas Zykus,Ruta Kucinskiene,Daniela Lazăr,Inna Nikulina,Luísa Castro,Juan-Ramon Pineda,Santos Pereira,Jesús Martínez-Cadilla,Luciano Sanroman,Montserrat Figueira,David Martinez Ares,Jose-Ignacio Rodriguez-Prada,Amalia Carmona,Carlos Gonzalez-Portela,Ulla-Britt Widen,Sally Myers,Katherine Ashton,Emma Whitehead +92 more
TL;DR: Overall direct expenditure on health care decreased over a 5-year follow-up period, characterised by increasing expenditure on biologicals and decreasing expenditure on conventional medical treatments, hospitalisations, and surgeries.
Journal ArticleDOI
Health-related quality of life improves during one year of medical and surgical treatment in a European population-based inception cohort of patients with inflammatory bowel disease--an ECCO-EpiCom study.
Johan Burisch,Petra Weimers,Natalia Pedersen,Silvija Čuković-Čavka,Boris Vucelić,I. Kaimakliotis,Dana Duricova,Martin Bortlik,Olga Shonová,Ida Vind,Søren Avnstrøm,Niels Thorsgaard,Sussane Krabbe,Vibeke Andersen,Jens Frederik Dahlerup,Jens Kjeldsen,Riina Salupere,John Olsen,K R Nielsen,Pia Manninen,Pekka Collin,Konstantinnos H. Katsanos,Epameinondas V. Tsianos,K. Ladefoged,Laszlo Lakatos,G. Ragnarsson,Einar Bjornsson,Y. Bailey,Colm O'Morain,Doron Schwartz,Selwyn Odes,D. Valpiani,MC Boni,Laimas Virginijus Jonaitis,Limas Kupčinskas,Svetlana Turcan,L. Barros,Fernando Magro,Daniela Lazăr,Adrian Goldis,Inna Nikulina,Elena Belousova,Alberto Fernandez,L Sanroman,Sven Almer,Yaroslava Zhulina,Jonas Halfvarson,Naila Arebi,T Diggory,Shaji Sebastian,Peter L. Lakatos,Ebbe Langholz,Pia Munkholm +52 more
TL;DR: The majority of IBD patients in both Eastern and Western Europe reported a positive perception of disease-specific but not generic HRQoL, and medical and surgical treatment improved HRZoL during the first year of disease.